GHR and Parkinson disease: We found four top biomarker candidates—ACY1, BSP, GHR, and OMD—that replicated across a single-site Discovery Cohort and a multisite Replication Cohort, were robust to common sources of preanalytical variability, and did not differ in paired samples from PD participants on versus off dopaminergic medication.